Speaker Profile
Ph.D., CEO, Dxcover
Biography
Prof. Baker is the co-founder of Dxcover, a clinical-stage company pioneering multi-cancer early detection using advanced infrared spectroscopy and multi-omic AI analysis. A recognised leader in spectroscopic diagnostics, he has driven the development of a platform capable of delivering rapid, low-cost blood tests for early-stage cancer detection across multiple tumour types.Matt has led Dxcovers expansion across Europe and the United States, including the establishment of a CLIA laboratory in Nashville and the advancement of major regulatory pathways such as CE-IVDR and UKCA. His work has contributed to more than 150 scientific publications and multiple patents focused on translating laboratory innovations into clinical tools with real-world impact.He is passionate about transforming population health through accessible early detection AI technologies and is currently guiding Dxcover through its next phase of commercial and clinical growth.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Victor Velculescu, Johns Hopkins
PMWC Award Ceremony
• Klaus Pantel, UKE & ELBS
• Daniel De Carvalho, University of Toronto
Keynote
• Klaus Pantel, UKE & ELBS
From Mutation to Methylation: The Next Wave of Liquid Biopsy Biomarkers
• Chair: Victor Velculescu, Johns Hopkins
• Daniel De Carvalho, University of Toronto
• Manel Esteller, Sant Pau Research Institute
Advancing Minimal Residual Disease (MRD) Detection through cfDNA and cfRNA Profiling
• Chair: Luis Diaz, MSKCC
• Anne-Renee Hartman, Adela
• Klaus Pantel, UKE & ELBS
AI-Informed Biomarker Trials: Turning Early Detection Signals into Clinically Actionable Designs
• Chair: Manish Kohli, University of Utah
• Luis Diaz, MSKCC
• Amoolya Singh, DELFI Diagnostics
• Peter Bach, DELFI Diagnostics
Fragmentomics for Early Detection: End Motifs and Library Prep
• Varsha Rao, Claret Bioscience
Integrating Genetic Risk with Early Detection: A Precision Prevention Framework for Cardiovascular Disease
• Giordano Botta, Allelica
Role of AI in Liquid Biopsies and Cancer Detection
• Chair: Amoolya Singh, DELFI Diagnostics
• Matthew Baker, Dxcover
